These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7818564)

  • 21. Plasma thiopurine S-methyltransferase levels and azathioprine-related adverse events in patients with Behçet's disease.
    Emmungil H; Durusoy R; Kalfa M; Yargucu Zihni F; Özmen M; Keser G; Gücenmez S; Yilmaz Z; Aksu K
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S40-5. PubMed ID: 25936353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations in patients with chronic inflammatory diseases.
    Schedel J; Gödde A; Schütz E; Bongartz TA; Lang B; Schölmerich J; Müller-Ladner U
    Ann N Y Acad Sci; 2006 Jun; 1069():477-91. PubMed ID: 16855176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thiopurine methyltransferase (TPMT) genotype distribution in azathioprine-tolerant and -intolerant patients with various disorders. The impact of TPMT genotyping in predicting toxicity.
    Reuther LO; Vainer B; Sonne J; Larsen NE
    Eur J Clin Pharmacol; 2004 Jan; 59(11):797-801. PubMed ID: 14634700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of genetic polymorphisms of azathioprine-metabolizing enzymes on response to rheumatoid arthritis treatment.
    Tsuchiya A; Aomori T; Sakamoto M; Takeuchi A; Suzuki S; Jibiki A; Otsuka N; Ishioka E; Kaneko Y; Takeuchi T; Nakamura T
    Pharmazie; 2017 Jan; 72(1):22-28. PubMed ID: 29441893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients.
    Chocair PR; Duley JA; Simmonds HA; Cameron JS
    Transplantation; 1992 May; 53(5):1051-6. PubMed ID: 1585469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine.
    Marra CA; Esdaile JM; Anis AH
    J Rheumatol; 2002 Dec; 29(12):2507-12. PubMed ID: 12465143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiopurine S-methyltransferase gene polymorphism is predictive of azathioprine-induced myelosuppression in heart transplant recipients.
    Sebbag L; Boucher P; Davelu P; Boissonnat P; Champsaur G; Ninet J; Dureau G; Obadia JF; Vallon JJ; Delaye J
    Transplantation; 2000 Apr; 69(7):1524-7. PubMed ID: 10798786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzymes involved in purine metabolism--a review of histochemical localization and functional implications.
    Moriwaki Y; Yamamoto T; Higashino K
    Histol Histopathol; 1999 Oct; 14(4):1321-40. PubMed ID: 10506947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.
    Zelinkova Z; Derijks LJ; Stokkers PC; Vogels EW; van Kampen AH; Curvers WL; Cohn D; van Deventer SJ; Hommes DW
    Clin Gastroenterol Hepatol; 2006 Jan; 4(1):44-9. PubMed ID: 16431304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.
    Fargher EA; Tricker K; Newman W; Elliott R; Roberts SA; Shaffer JL; Bruce I; Payne K
    J Clin Pharm Ther; 2007 Apr; 32(2):187-95. PubMed ID: 17381669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.
    Colombel JF; Ferrari N; Debuysere H; Marteau P; Gendre JP; Bonaz B; Soulé JC; Modigliani R; Touze Y; Catala P; Libersa C; Broly F
    Gastroenterology; 2000 Jun; 118(6):1025-30. PubMed ID: 10833476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects.
    Steponaitiene R; Kupcinskas J; Survilaite S; Varkalaite G; Jonaitis L; Kiudelis G; Denapiene G; Valantinas J; Skieceviciene J; Kupcinskas L
    Adv Med Sci; 2016 Mar; 61(1):135-40. PubMed ID: 26674571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-nucleotidase and azathioprine-related bone-marrow toxicity.
    Kerstens PJ; Stolk JN; Hilbrands LB; van de Putte LB; De Abreu RA; Boerbooms AM
    Lancet; 1993 Nov; 342(8881):1245-6. PubMed ID: 7901568
    [No Abstract]   [Full Text] [Related]  

  • 34. Synovial fluid 5'-nucleotidase activity. Relationship to other purine catabolic enzymes and to arthropathies associated with calcium crystal deposition.
    Wortmann RL; Veum JA; Rachow JW
    Arthritis Rheum; 1991 Aug; 34(8):1014-20. PubMed ID: 1650220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of thiopurine methyltransferase (TPMT) polymorphisms cannot predict myelosuppression in systemic lupus erythematosus patients taking azathioprine.
    Naughton MA; Battaglia E; O'Brien S; Walport MJ; Botto M
    Rheumatology (Oxford); 1999 Jul; 38(7):640-4. PubMed ID: 10461478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limitations of extensive TPMT genotyping in the management of azathioprine-induced myelosuppression in IBD patients.
    Dewit O; Moreels T; Baert F; Peeters H; Reenaers C; de Vos M; Van Hootegem P; Muls V; Veereman G; Mana F; Van Outryve M; Holvoet J; Naegels S; Piessevaux H; Horsmans Y; Gala JL;
    Clin Biochem; 2011 Sep; 44(13):1062-1066. PubMed ID: 21723857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.
    Meggitt SJ; Gray JC; Reynolds NJ
    Lancet; 2006 Mar; 367(9513):839-46. PubMed ID: 16530578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study.
    Gisbert JP; Luna M; Maté J; González-Guijarro L; Cara C; Pajares JM
    Hepatogastroenterology; 2006; 53(69):399-404. PubMed ID: 16795981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Azathioprine-associated acute myeloid leukemia in a patient with Crohn's disease and thiopurine S-methyltransferase deficiency.
    Yenson PR; Forrest D; Schmiegelow K; Dalal BI
    Am J Hematol; 2008 Jan; 83(1):80-3. PubMed ID: 17696202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Optimising azathioprine treatment: determination of thiopurine methyltransferase activity and thiopurine metabolites].
    Alvarez Beltran M; Infante Pina D; Tormo Carnicé R; Segarra Cantón O; Redecillas Ferreiro S
    An Pediatr (Barc); 2009 Feb; 70(2):126-31. PubMed ID: 19217567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.